According to the 2013 Arrowhead TBI conference website "Treatment of TBI and especially acute TBI is still a major unmet medical need. Therapies that prove an ability to limit the damage done to the brain and improve clinical outcomes of patients of TBI will have a major impact on the global pharmaceutical market. Although past clinical trials for new therapies have ended in failure, there is indeed renewed interest in this field and with recent initiatives from both the U.S. Congress and Department of Defense to improve treatment options for TBI patients, the time has come for a rethinking of the potential for pharmaceutical management of this condition."
It won't affect Isonep, Asonep or phase 1 Lpathomab now that they have enough money to do all that.
It may keep the DOD from doing the test they want to do, but who knows. I don't think it's a ton of money for the DOD to spend, and they aren't cutting all research.... We don't even know if there will be a sequester, so nobody knows. Except Charles, who is very concerned, all the time.
i dont think it will hurt the chances of a dod partnership. back in september the administration allocated 100 million for ptsd and tbi research. i dont think that they have spent all that money. the other think to keep in mind is that tbis are a high priority for the military. im sure they could scrounge up a few million from the couch cushions if needed.